Escherichia coli and Klebsiella pneumoniae are responsible for UTI in 80-90% cases [2] [3] [4] . Extended-spectrum beta-lactamase (ESBL) producing E. coli and K. pneumoniae are increasingly being isolated in cultures from urine samples in Bangladesh 5-8 . Advanced age, diabetes mellitus (DM), use of urinary catheters, previous hospital admission and antibiotic intake are reported as risk factors for ESBL positivity 9, 10 . Data regarding ESBL positive organisms are limited in our country. This study was designed to describe the frequency of ESBL positive E. coli and K. pneumoniae causing UTI, their associated risk factors and antibiotic sensitivity pattern in a tertiary care setting of Bangladesh.
Culture negative UTI cases and UTI due to organisms other than E. coli and K. pneumoniae were excluded from the study. Data were collected in pre-designed case record forms from the study subjects including demographic characteristics, co-morbidities, clinical presentation and investigations. Data were analyzed by statistical package for social sciences (SPSS) version 15.
Results :
Total patients were 100 (out of 124 culture positive UTI cases during the study period), male were 21 and female 79. Mean age was 59.1 ± 11.7 (range 19-81) years. Base-line characteristics are presented in table I. Common co-morbidities were DM, hypertension, chronic kidney disease (CKD) and dyslipidemia. Other co-morbidities are  presented in table II.   Fever, vomiting, dysuria and increased urinary frequency  were common symptoms (table III) . Among the 100 culture positive samples, E. coli were 84 and K. pneumoniae were 16. Forty eight (48/84, 57.1%) of E. coli and 10 (10/16, 62.5%) of K. pneumoniae were ESBL positive. Female patients, long duration and uncontrolled DM, past history of UTI, CKD and renal stone were significant risk factors for ESBL positivity (table IV) . Amikacin, netilmycin, imipenem and nitrofurantoin were among the most sensitive antibiotics (table V). ESBL positive organisms are now a global health threat 11 . These organisms have implications on physicians and patients; they are associated with treatment failure, increased morbidity and mortality, prolonged hospital stay, poor outcome and increased health care costs 12 . In this study, we have evaluated the frequency of ESBL positive E. coli and K. pneumoniae causing UTI, their associated risk factors and antibiotic sensitivity patterns.
Mean age of our study population was just below 60 years. In two different reports from Dhaka, Bangladesh, patients suffering from UTI were of much lower age, but patients having infections due to ESBL positive organisms had a mean age of 71 years in Spain 6, 9, 13 . In current study, it was seen that, 57% of E. coli and 62.5% of K. pneumoniae were positive for ESBL. This frequency is much higher than previous four reports from Bangladesh 5, 6, 13, 14 . ESBL positive organisms are also increasingly being identified in Korea 15 and USA 16 . In Korea, it was 3.6% in 2006 and 14.3% in 2011 and in USA it was 4% in 2006 and 14% in 2012. In one report from Nepal, ESBL positivity for E. coli and K. pneumoniae from urine samples were 13.41% and 16.55% respectively 17 . One North Indian report showed these figures as 5% and 13% respectively 10 .
Female patients, presence of DM, long duration and poor control of DM, CKD, renal stone and past history of UTI were risk factors for ESBL positivity in our study. Long hospital stay (>3 days), past history of UTI and prior antibiotic use were risk factors in a study from Spain 9 . DM and increasing age were noted as risk factors for ESBL positivity in one report from India 10 .
Regarding antibiotic sensitivity patterns, most organisms were sensitive to imipenem and amikacin in our study. As CKD was a common co-morbid condition in our study population, we preferred carbapenems. Carbapenems were the most sensitive antibiotic as reported from India .
The study duration was short and sample size was small. It was a hospital-based study and most of the patients were diabetic. It is not clear whether pattern of micro-organisms causing UTI and their ESBL positivity and antibiotic sensitivity differ from non-diabetic population and in community.
In conclusion, it can be said that two-thirds of the E. coli and K. pneumoniae causing UTI were ESBL positive. Female patients, presence of DM, long duration and poor control of DM, past history of UTI, CKD and renal stone were important risk factors for ESBL positivity. Carbapenems remain the drug of choice. It might be recommended that urine samples should be sent for culture and antibiotic sensitivity test before starting antibiotic in suspected UTI cases and every laboratory should routinely screen for ESBL positivity.
